IMMUNOTEC RESEARCH, INC

Throughout history, there have been discoveries that have had a tremendous impact on the lives of mankind. In many cases, these discoveries have only come along once in several lifetimes. Immunocal and Immunocal Platinum, are two of those amazing discoveries that only come along every now-n-then. These exceptional products can optimize a weakened immune system.

Wednesday, March 13, 2013

CAN’T KEEP THE WEIGHT OFF???

INTRODUCING!!!





Developed with whey protein, the highest biological value of any edible protein.
Featuring the Revolutionary Calorie Confusion Meal Plan

Calorie confusion
We’ve designed a meal plan where you vary your daily caloric intake to reduce fat and support lean muscle growth which will confuse your metabolism. If your body doesn’t know how much food it will receive, your metabolism will not have time to adjust or lay down fat tissue.

Benefits of the system
Designed to offer you long-term solutions • Not only helps you realize your weight loss goal, it also encourages and educates you to lead a healthier lifestyle once your goal is reached • Increases your nutrition and exercise knowledge • Helps you enjoy a better quality of life


                              
MiFORM Transformation Kit                    MiFORM Maintenance Kit










Achieve your weight loss goal!  
A structured calorie confusion meal plan combining the Transformation Kit products along with healthy food choices and  exercise.

Congratulation!
You have achieved your weight loss goal, now it’s time to keep shape for life!  Maintain your optimal weight by eating right and supplementing with Immunocal.


888-766-9480

 JOHNNY ROBINSON
Retired Army:  First Sergeant
Disabled Vietnam Veteran








Friday, February 15, 2013

OVARIAN CANCER STATISTICS and POSSIBLE SOLUTION


Statistical Information From:  American Cancer Society, Cancer Facts & Figures 2013



Statistics

In the United States, doctors must report any diagnosis of cancer to a state registry.  The federal government, through the Center for Disease Control and Prevention's National Program for Cancer Registries, overseer the registries in 45 states, the District of Columbia, and three territories.  The Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute funds the remaining five statewide cancer registries.  Together the two programs cover the country's population.  

The following statistics come primarily from the most recent findings of the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute. SEER numbers are age-adjusted and based on actual data; SEER data is available for most data through 2009. More recent statistics, such as 2013 incidence numbers, are projections from the American Cancer Society.  

The American Cancer Society estimates that in 2013, about 22,240 new cases of ovarian cancer will be diagnosed and 15,500 women will die of ovarian cancer in the United States.

According to the data, the mortality rates for ovarian cancer have not improved in forty years since the “War on Cancer” was declared. However, other cancers have shown a marked reduction in mortality, due to the availability of early detection tests and improved treatments. Unfortunately, this is not the case with ovarian cancer, which is still the deadliest of all gynecologic cancers.

The Surveillance, Epidemiology and End Results (SEER) Program reports that on January 1, 2009 in the United States approximately 182,758 women were alive who had been diagnosed with ovarian cancer (including those who had been cured of the disease).
YearIncidenceDeaths
199919,67613,627
200019,67214,060
200119,71914,414
200219,79214,682
200320,44514,657
200420,06914,716
200519,84214,787
200619,99414,487
200720,74914,621
200821,61314,362
200920,46014,436
2010 (Projected)21,88013,850
2011 (Projected)21,99015,460
2012 (Projected)22,28015,500
2013 (Projected)22,24014,030
Ovarian cancer accounts for approximately three percent of cancers in women. While the 10th most common cancer among women, ovarian cancer is the fifth leading cause of cancer-related death among women, and is the deadliest of gynecologic cancers. Mortality rates are slightly higher for Caucasian women than for African-American women.  

A Woman’s Lifetime Risk: A woman’s lifetime risk of developing invasive ovarian cancer is 1 in 72.  A woman’s lifetime risk of dying from invasive ovarian cancer is 1 in 95.

Age:
Approximately 1.2 percent were diagnosed under age 20; 3.6 percent between 20 and 34; 7.4 percent between 35 and 44; 18.6 percent between 45 and 54; 23.4 percent between 55 and 64; 20.1 percent between 65 and 74; 17.6 percent between 75 and 84; and 8.1 percent 85+ years of age.

Click to enlarge
From 2005 to 2009, the median age at diagnosis was 63. For the same period, the median age of death from ovarian cancer was 71.
Survival:
Survival rate and diagnosis for varied stages between 2002 and 2008.
Ovarian cancer survival rates are much lower than other cancers that affect women.
  • The relative five-year survival rate is 44 percent. Survival rates vary depending on the stage of diagnosis.
  • Women diagnosed at an early stage have a much higher five-year survival rate than those diagnosed at a later stage.
  • Approximately 15 percent of ovarian cancer patients are diagnosed early.2
  • Women diagnosed with breast cancer in 1975 experienced a five-year survival rate of 75.3 percent; today, the American Cancer Society estimates the rate to be 90 percent.
  • Women diagnosed with cervical cancer in 1975 experienced a five-year survival rate of 69 percent; today, the American Cancer Society estimates the rate to be 69 percent.
  • Women diagnosed with ovarian cancer in 1975 experienced a five-year survival rate of 36 percent; today, the American Cancer Society estimates the rate to be 43 percent.

We have an amazing product that is Patented, Scientifically & Clinically Proven and Guaranteed to help in 30 days or your money back.  GUARANTEED!!!
888-766-9480

 JOHNNY ROBINSON
Retired Army:  First Sergeant
Disabled Vietnam Veteran (Exposed to Agent Orange)

This product has sent all my problems into remission by optimizing my immune system.

Heart Desease ( WWW.JROBPRODUCTS.COM )

Ovarian Cancer ( WWW.JROBPRODUCTS.COM )

Saturday, January 5, 2013

SARCOIDOSIS


"Doctors Recommended Lifelong Immuno-suppressive Therapy"




In 1997, I was diagnosed with a very aggressive, Pulmonary disease [called] “stage 3 Sarcoidosis.” This is an autoimmune disease that causes inflammation and scaring of the lung tissue. I was already losing vital lung function and in time I would become a lung cripple, no longer able to breathe without the aid of an oxygen tank.

My doctors recommended that I began a lifelong immuno-suppressive therapy-using Steroids. I was further in formed that the benefits from the steroid treatment could not be guaranteed but the long-term prognosis without the treatment is probably worse.

In June of 1999 I started using a high dose of Prednisone. The drug Plaquenil was later added. Modest improvement came at the expense of many side effects including abnormal weight gain, muscular weakness, a [bloated] look in my face, pain in my joints and the swelling of my fingers. Since immuno-suppressive therapy did not provide me with the results I was looking for, I discontinued the treatment in April 2001. I then started looking for a nutritional solution to support my immune system.

In addition to juicing, I made some major changes in my eating habits. In October 2001, I started taking Chinese herbs to further support my immune system. The Doctors began to see some major clinical improvements. Some weeks latter an old friend by the name of Jim Spencer contacted me and recommended that I start taking a product called Immunocal. He pointed out that my auto Immune disease was a result of a glutathione deficiency. He further pointed out that Immunocal is listed in the “Physicians Desk Reference” (the doctor’s bible).

When I checked the PDR I was surprised to learn that there are many diseases listed in that publication that are defined as “Glutathione Deficient States” with autoimmune diseases being among them. The PDR further states that Immunocal has been “clinically proven to raise glutathione values” in each cell of the body.

Jim said that raising my glutathione levels by using Immunocal would not only regulate my immune system so that the inflammation would go away, but the elevated glutathione levels would also rid my body of all the toxins I received as a result of taking those very powerful medications.

In just three months after using Immunocal, the inflammation had completely gone away with no further scaring of my lung tissue. My lung function has dramatically improved to the amazement of all of my doctors. Finally, as my body began riding itself of all the toxins, the side effects from the medications began to fade away. Other than immunocal and the other vitamin supplements from Immunotec Research, I am on no other Pharmaceuticals or herbal remedies to prevent the return of this disease. At the time of this writing it had been six years since I started seeing the benefits of elevating my glutathione levels by adding Immunocal to my daily regimen. (December 2007)
 ——
The people giving product testimonials on this BLOG or on other Immunotec material reflect the actual experience of each individual, are anecdotal only, and may be atypical. These statements have not been approved by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. This notice is required by the Federal Food, Drug and Cosmetic Act.



IMMUNOCAL IS GUARANTEED TO RAISE GLUTATHIONE VALUES AND OPTIMIZE YOUR IMMUNE SYSTEM IN 30 DAYS OR YOUR MONEY BACK.  GUARANTEED!!!

www.jrobproducts.com

JOHNNY ROBINSON
Retired Army:  First Sergeant
Disabled Vietnam Veteran (Exposed to Agent Orange)

This product has sent all my problems into remission by optimizing my immune system.